Dermatology

1-16 of 28

Can We Prevent Psoriatic Arthritis Before Diagnosis?
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Living Rheum
Can We Prevent Psoriatic Arthritis Before Diagnosis?
- Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living Rheum
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living Rheum
Defining the Challenge in Complex Cases of Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
AudioAbstracts
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
- Ryan Quigley
Progress and Practical Limits with AI in Psoriatic Arthritis
Progress and Practical Limits with AI in Psoriatic Arthritis
AudioAbstracts
Progress and Practical Limits with AI in Psoriatic Arthritis
- Ryan Quigley
Molecular Signals and Early Detection in Psoriatic Arthritis
Molecular Signals and Early Detection in Psoriatic Arthritis
Living Rheum
Molecular Signals and Early Detection in Psoriatic Arthritis
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Clinician's Roundtable
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
- Atul A. Deodhar, MD, MRCP
Psoriasis and Arthritis Care: Examining the Impact of Unmet Needs
Psoriasis and Arthritis Care: Examining the Impact of Unmet Needs
Clinician's Roundtable
Psoriasis and Arthritis Care: Examining the Impact of Unmet Needs
- Atul A. Deodhar, MD, MRCP
Treating Skin Manifestations of Connective Tissue Diseases
Treating Skin Manifestations of Connective Tissue Diseases
Clinician's Roundtable
Treating Skin Manifestations of Connective Tissue Diseases
Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
Clinician's Roundtable
Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
- Charles Turck, PharmD, BCPS, BCCCP
- Ananta Paine, PhD
Screening for Axial Involvement in Psoriatic Patients
Screening for Axial Involvement in Psoriatic Patients
On the Frontlines of Psoriasis
Screening for Axial Involvement in Psoriatic Patients
- Matthew S. Keller MD
- Monica Schwartzman, MD, MS
Psoriatic Disease in People of Color: How Can We Close the Diagnostic Gap?
Psoriatic Disease in People of Color: How Can We Close the Diagnostic Gap?
DermConsult
Psoriatic Disease in People of Color: How Can We Close the Diagnostic Gap?
- Michael Greenberg, MD
- Lynn McKinley-Grant, MD, FAAD
A Multidisciplinary Approach to Care Coordination Challenges in Psoriatic Arthritis
A Multidisciplinary Approach to Care Coordination Challenges in Psoriatic Arthritis
Beyond Skin Deep: Impacts of Psoriatic Arthritis
A Multidisciplinary Approach to Care Coordination Challenges in Psoriatic Arthritis
- Michael Greenberg, MD
- Madelaine A. Feldman, MD, FACR
Unrecognized Comorbidities of Psoriatic Arthritis
Unrecognized Comorbidities of Psoriatic Arthritis
Beyond Skin Deep: Impacts of Psoriatic Arthritis
Unrecognized Comorbidities of Psoriatic Arthritis
- Alexis Ogdie, MD, MSCE

1/2

Dermatology

1-16 of 28

CONTACT US

(866) 423-7849

CONTACT US

(866) 423-7849

1-16 of 28

Title

Share on ReachMD